Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 3 studies | 18% ± 3% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
epithelial cell | 3 studies | 31% ± 5% |
Insufficient scRNA-seq data for expression of ZNF830 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 943.99 | 459 / 459 | 100% | 29.81 | 1118 / 1118 |
esophagus | 100% | 828.35 | 1445 / 1445 | 100% | 16.34 | 183 / 183 |
lung | 100% | 756.70 | 578 / 578 | 100% | 22.65 | 1155 / 1155 |
prostate | 100% | 923.96 | 245 / 245 | 100% | 31.10 | 502 / 502 |
intestine | 100% | 953.90 | 966 / 966 | 100% | 22.46 | 526 / 527 |
kidney | 100% | 711.62 | 89 / 89 | 100% | 21.55 | 899 / 901 |
ovary | 100% | 998.74 | 180 / 180 | 100% | 16.38 | 429 / 430 |
pancreas | 100% | 492.70 | 327 / 328 | 100% | 24.42 | 178 / 178 |
thymus | 100% | 1017.89 | 653 / 653 | 100% | 29.28 | 603 / 605 |
stomach | 100% | 763.83 | 359 / 359 | 100% | 20.40 | 285 / 286 |
brain | 100% | 650.10 | 2632 / 2642 | 100% | 31.48 | 705 / 705 |
uterus | 100% | 1023.27 | 170 / 170 | 99% | 29.67 | 456 / 459 |
bladder | 100% | 783.33 | 21 / 21 | 99% | 23.85 | 500 / 504 |
skin | 100% | 950.17 | 1809 / 1809 | 99% | 24.11 | 468 / 472 |
liver | 100% | 579.88 | 226 / 226 | 97% | 14.07 | 394 / 406 |
adrenal gland | 100% | 669.60 | 258 / 258 | 97% | 16.31 | 223 / 230 |
adipose | 100% | 852.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 713.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.18 | 29 / 29 |
spleen | 100% | 1592.62 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.04 | 1 / 1 |
muscle | 99% | 420.56 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 440.68 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 17.37 | 77 / 80 |
peripheral blood | 89% | 586.03 | 831 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001832 | Biological process | blastocyst growth |
GO_0006397 | Biological process | mRNA processing |
GO_0044773 | Biological process | mitotic DNA damage checkpoint signaling |
GO_0033260 | Biological process | nuclear DNA replication |
GO_0001546 | Biological process | preantral ovarian follicle growth |
GO_0001541 | Biological process | ovarian follicle development |
GO_0006396 | Biological process | RNA processing |
GO_0051301 | Biological process | cell division |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0008380 | Biological process | RNA splicing |
GO_0051276 | Biological process | chromosome organization |
GO_0033314 | Biological process | mitotic DNA replication checkpoint signaling |
GO_0060729 | Biological process | intestinal epithelial structure maintenance |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ZNF830 |
Protein name | Zinc finger protein 830 (Coiled-coil domain-containing protein 16) Zinc finger protein 830 |
Synonyms | CCDC16 |
Description | FUNCTION: May play a role in pre-mRNA splicing as component of the spliceosome . Acts as an important regulator of the cell cycle that participates in the maintenance of genome integrity. During cell cycle progression in embryonic fibroblast, prevents replication fork collapse, double-strand break formation and cell cycle checkpoint activation. Controls mitotic cell cycle progression and cell survival in rapidly proliferating intestinal epithelium and embryonic stem cells. During the embryo preimplantation, controls different aspects of M phase. During early oocyte growth, plays a role in oocyte survival by preventing chromosomal breaks formation, activation of TP63 and reduction of transcription (By similarity). . |
Accessions | Q96NB3 J3QQQ3 ENST00000361952.5 ENST00000578339.1 |